Study about Conjunctivitis and various treatment outcomes.

Clinical features,diagnosois and therapeutic outcomes of Acute Viral Conjunctivitis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051943

Enrollment

Registered

2023-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

Intervention1: 0.5%moxifloxacin and 0.5%lotepred eyedrops: topical antibiotics and topical steroid eyedrops 4 times a day till resolution Intervention2: 0.15% ganciclovir eye ointment: topical eye oin

Eligibility

Inclusion criteria

Inclusion criteria: 1]All patients who were clinically diagnosed to have viral conjunctivitis based on history and slit lamp examination 2]Age >14 years

Exclusion criteria

Exclusion criteria: 1. Patient with prior treatment for conjunctivitis 2. Pregnant and lactating patients 3. Active corneal involvement 4. Ocular surface diseases 5. k/c/o of glaucoma ,active uveitis 6. Patients with concomitant bacterial/fungal conjunctivitis 7. Patient unwilling for the study 8. patient losing follow up 9. bacterial swab test positive patients.

Design outcomes

Primary

Measure	Time frame
resolution of signs and symptoms of acute viral conjunctivitisTimepoint: every 7th day	—

Secondary

Measure	Time frame
to find out whether topical antivirals prevent secondary corneal complicationsTimepoint: every 7th day	—

Countries

India

Contacts

Public ContactDR SUDHAKAR POTTI

SANKARA EYE HOSPITAL GUNTUR

sudhakar@sankaraeye.com9705190929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026